Respiratory Flashcards
50% decrease in airflow, >10 seconds, more than 15 seconds/hour of sleep, results in 4% decrease in O2 sats
hypopnea
Snoring, complete or partial obstruction of the airway during sleep + frequent episodes of apnea or hypopnea
Obstructive sleep apnea
Obesity, awake arterial hypercapnia, insufficient alveolar impairment indecent of any other pulmonary disease
Obesity hypoventilation syndrome
Obesity, awake arterial hypercapnia, insufficient alveolar impairment indecent of any other pulmonary disease
Obesity hypoventilation syndrome
What is hepatopulmonary syndrome?
Hypoxemia due to liver disease
What are the defining characteristics of hepatopulmonary disease?
- Presence of portal hypertension
- Increase Aa gradient
- Intrapulmonary vasodilation
Bronchoconstriction pathway
PNS- vagal stimulation
released Ach acts on M3 to stim Gq
phospholipase C is activated
converts PIP2 to IP3
IP3 stims Ca release from sarcoplasmic reticulum
bronchoconstriction results
How is bronchoconstriction from PNS stimulation turned off
IP3 phosphatase deactivates IP3 to IP2
How do mast cells promote bronchoconstriction:
Coughing, allergy, or infection activate IgE, cytokines, and complement -> amplification of allergic response
Do non-cholinergic C-fibers promote bronchodilator or bronchoconstriction?
bronchoconstriction
Identify Mast Cell mediators and their respective receptors
Histamine -> Histamine 1
Prostaglandins D2 and F2 -> Thromboxane-specific prostanoid receptor
Leukotrienes C4, D4, and E4 -> CysLT1
Platelet activating factor -> PAF
Bradykinin -> Bradykinin 2
Name C-fiber mediators and their respective receptors:
Substance P -> Neurokinin-2
Neurokinin A -> GCRP
Calcitonin gene related peptide
Bronchodilation pathway due to Circulating Catecholamines
B2 Receptors activated by circulating catecholamines
Gs protein activated
adenylate cyclase activated
cAMP activated
cAMP and protein kinase A reduce Ca release from sarcoplasmic reticulum
smooth muscle contraction decreased
bronchodilation results
How is bronchodilation from circulating catecholamines turned off
Phosphodiesterase 3 deactivates cAMP by converting it to ATP
NO and bronchodilation
potent smooth muscle relaxant
vasoactive intestinal peptide released onto airway smooth muscle by non-cholinergic PNS nerves
NO production increased
stimulates cGMP
smooth muscle relaxation and bronchodilation result
Two ways B2 Agonists cause bronchodilation:
B2 stim -> increased cAMP -> decreased iCa+2
Stabilizes mast cell membranes -> decreased mediator release
B2 agonist examples and side effects
Albuterol, salmeterol, metproteronol
tachycardia, dysrhythmias, hypoK, hyperglycemia, tremors
How do anticholinergics promote bronchodilation:
Antagonize M3R -> decrease IP3 -> decrease iCa+2
Two ways inhaled corticosteroids cause bronchodilation:
Stimulate intracellular steroid receptors
Regulate inflammatory protein synthesis (results in decreased airway inflammation and decreased airway hyperresponsiveness
Cromolyn and bronchodilation
Mast cell membrane stabilizer
(blocks cytokines, leukotrienes, histamine)?
Leukotriene modifier MOA
Inhibit 5-lipooxygenase enzyme (decreased leukotriene synthesis)
Three ways methylxanthines work and give an example
Theophylline
Inhibit PDE -> increase cAMP
Increase endogenous catecholamine release
Inhibit adenosine receptors
Define static lung volumes
How much air the lungs can hold at one time
Define Dynamic lung volumes
How quickly air can be moved in and out of the lungs over time
Normal Tidal Volumes
500 mL
Normal inspiratory reserve volume
3,000 mL
Normal end residual volume
1,100 mL
Normal residual volume
1,200 mL
Define FEV1 and the normal value
Forced Expiratory Volume in 1 second
Volume let out in 1 second after a maximum inhalation
-depends on patient effort
-declines with age
normal= >80% predicted value
Define forced vital capacity and its normal value
Volume of air exhaled after a maximum inhalation
Male = 4.8 L
Female = 3.7 L
FEV1 to FVC ratio normal value and use
75 - 80% predicted value
Used to distinguish between restrictive and obstructive
<70% = obstructive
normal with restrictive
Forced expiratory flow at 25-75% vital capacity is:
aka Mid maximal expiratory flow rate
Measure airflow in the middle of FEV
Normal: 100 +/- 25% predicted value
What is FEV25-75% used to indicate?
Small airway disease - most sensitive indicator
Usually reduced with obstructive
Usually normal with restrictive
Maximum voluntary ventilation is:
Endurance test
Max volume of air inhaled and exhaled over 1 minute
Normal Male= 140-180L
Normal Female = 80-120L
Another name for FEV 25-75%
Mid maximal expiratory flow rate (MMEF)
Another name for FEV 25-75%
Mid maximal expiratory flow rate (MMEF)
Postop pulmonary comp risk factors: patient
age > 60
ASA > 2
CHF
COPD
Cigarette smoking (>40 pack years
Postop pulmonary comp risk factors: procedure
aortic > thoracic > upper abdominal ~ neuro ~ peripheral vascular > emergency
general anesthesia
duration of surgery > 2 hours
Postop pulmonary comp risk factors: diagnostic testing
albumin < 3.5 g/dL
-indicates poor nutritional status
Factors NOT shown to increase postop pulmonary comps
mild/moderate asthma
arterial blood gas analysis
pulmonary function testing